Given that AhR is a key target of environmental toxicants [219,220] and that tryptophan catabolites act as AhR ligands in the developmental programming of kidney disease [253], tryptophan metabolites hold potential to counteract environmental toxicant–induced kidney injury in offspring, highlighting the need for further studies to define their protective mechanisms. The gene discussed is AHR; the disease is medical procedure.